Progress in simulation modelling for pharmacokinetics

Area of Science:

• Pharmacokinetics and Drug Metabolism
• Computational Biology
• Systems Pharmacology

Background:

• Physiologically-based pharmacokinetic (PBPK) models are crucial for predicting drug behavior in humans and other species.
• These mechanistic models integrate physiological parameters with drug-specific information to simulate absorption, distribution, metabolism, and elimination (ADME).

Purpose of the Study:

• To review existing simulation models for predicting human pharmacokinetics.
• To explain the structure and mathematical details of PBPK models.
• To discuss advanced modeling approaches for complex tissues and drug interactions.

Main Methods:

• Review of literature on PBPK models.
• Explanation of mathematical representations of organ blood flow and distribution.
• Discussion of modeling techniques for specific tissues (e.g., liver, tumors) and transport processes (e.g., biliary secretion).
• Overview of experimental and in silico methods for ADME property estimation.
• Description of gastro-intestinal transit modeling and drug-drug interaction simulations.

Main Results:

• PBPK models provide a mechanistic framework for understanding and predicting drug pharmacokinetics.
• Various mathematical approaches exist for representing physiological processes and drug distribution.
• Modeling can be extended to complex biological systems and drug-drug interactions.

Conclusions:

• PBPK modeling is a versatile tool for pharmacokinetic prediction across species.
• The review highlights the evolution and application of PBPK models in drug development.
• Advanced PBPK models can simulate complex physiological processes and predict drug interactions.